Get complete Patent Opposition Report for Serenity Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Serenity Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2442821Feb 12, 2025Safe Desmopressin Administration1
EP2381923Jun 7, 2023Safe Desmopressin Administration1
EP3278809Nov 20, 2019Safe Desmopressin Administration1